Comparative assessment of photodynamic therapy for typical age-related macular degeneration and polypoidal choroidal vasculopathy: a multicenter study in Hyogo prefecture, Japan.

Comparative assessment of photodynamic therapy for typical age-related macular degeneration and polypoidal choroidal vasculopathy: a multicenter study in Hyogo prefecture, Japan.

Item
http://www.wikidata.org/entity/Q45991599
Polypoidal choroidal vasculopathy: an angiographic discussion.Genetic risk, ethnic variations and pharmacogenetic biomarkers in age-related macular degeneration and polypoidal choroidal vasculopathyThe association of age-related maculopathy susceptibility 2 polymorphisms with phenotype in typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.Difference between age-related macular degeneration and polypoidal choroidal vasculopathy in the hereditary contribution of the A69S variant of the age-related maculopathy susceptibility 2 gene (ARMS2).The association of CD36 variants with polypoidal choroidal vasculopathy compared to typical neovascular age-related macular degeneration.Optical Coherence Tomographic Features and Prognosis of Pneumatic Displacement for Submacular Hemorrhage.Positive association of CD36 gene variants with the visual outcome of photodynamic therapy in polypoidal choroidal vasculopathy.ARMS2 variants may predict the 3-year outcome of photodynamic therapy for wet age-related macular degeneration.Effect of photodynamic therapy (PDT), posterior subtenon injection of triamcinolone acetonide with PDT, and intravitreal injection of ranibizumab with PDT for retinal angiomatous proliferation.Prognostic phenotypic and genotypic factors associated with photodynamic therapy response in patients with age-related macular degeneration.Visual outcome of photodynamic therapy for typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy over 5 years of follow-up.The association of age-related maculopathy susceptibility 2 (ARMS2) and complement factor H (CFH) variants with two angiographic subtypes of polypoidal choroidal vasculopathy.Polypoidal choroidal vasculopathy treatment options: A meta-analysis.One-year outcome of combination therapy with intravitreal aflibercept and verteporfin photodynamic therapy for polypoidal choroidal vasculopathy.Association of Genes in the High-Density Lipoprotein Metabolic Pathway with Polypoidal Choroidal Vasculopathy in Asian Population: A Systematic Review and Meta-Analysis.
P2860

Comparative assessment of photodynamic therapy for typical age-related macular degeneration and polypoidal choroidal vasculopathy: a multicenter study in Hyogo prefecture, Japan.

Item
http://www.wikidata.org/entity/Q45991599
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Comparative assessment of phot ...... dy in Hyogo prefecture, Japan.
@en
Comparative assessment of phot ...... dy in Hyogo prefecture, Japan.
@nl
type
label
Comparative assessment of phot ...... dy in Hyogo prefecture, Japan.
@en
Comparative assessment of phot ...... dy in Hyogo prefecture, Japan.
@nl
prefLabel
Comparative assessment of phot ...... dy in Hyogo prefecture, Japan.
@en
Comparative assessment of phot ...... dy in Hyogo prefecture, Japan.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Comparative assessment of phot ...... udy in Hyogo prefecture, Japan
@en
P2093
P304
P31
P356
P433
P478
P50
P577
P698